- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01115335
Feasibility, Acceptability, and Safety of Neonatal Male Circumcision in Lusaka, Zambia
Feasibility, Acceptability, and Safety of Neonatal Male Circumcision at the University Teaching Hospital in Lusaka, Zambia and in the Lusaka District in Zambia Using Gomco; Plastibell; and Mogen Methods
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As male circumcision becomes one component of Zambia's plan to prevent the spread of HIV, it is important to understand the acceptability, feasibility, and safety of implementing NMC services in various clinical settings.
In this study, we will examine the acceptability of neonatal male circumcision among parents in several ways. First, we will administer a structured questionnaire on NMC to 1000 consenting parents of newborn boys at a tertiary care institution and 1-2 primary care clinics in Lusaka. All parents approached, regardless of whether or not they complete the survey, will also be offered an opportunity to have their sons circumcised. Uptake will be calculated as the percent of parents approached who consent for their sons to be circumcised. Finally, we will assess parental satisfaction with results of the procedure.
To examine the feasibility of training providers and implementing neonatal male circumcision services in various clinical settings, we will train a group of 15-20 health care providers in three different circumcision methods (Gomco clamp, Mogen clamp, and Plastibell) at 2-3 study sites. We will recruit 600 infants to be circumcised during the training. We will use structured questionnaires and skill assessments to evaluate provider competence after completing the training curriculum, provider preferences among the three circumcision methods, and opinion about how NMC should be scaled up within the existing health care system. We will also document logistical difficulties of scaling up NMC services at the study sites.
Finally, we will examine the safety of implementing NMC by collecting and analyzing data on complications resulting from the different circumcision methods.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Lusaka, Zambia
- University Teaching Hospital and Matero Reference Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male infants who are in the first day of life (including infants < 24 hours old) and up to 4 weeks of age will be considered for circumcision
- Gestational age >37 weeks at birth
Exclusion Criteria:
- Any current illness
- Bleeding diathesis or family history of bleeding disorder
- Abnormality of urethra or penile shaft such as hypospadias
- Local infection defined as redness, swelling, or a purulent discharge from the infant penis
- Greater than four weeks of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Gomco
NMC performed using a Gomco clamp
|
Circumcision performed on a male infant within the first month of life, using one of 3 devices
|
|
Active Comparator: Mogen clamp
NMC performed using a Mogen clamp
|
Circumcision performed on a male infant within the first month of life, using one of 3 devices
|
|
Active Comparator: Plastibell
NMC performed using a Plastibell device
|
Circumcision performed on a male infant within the first month of life, using one of 3 devices
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication Rate
Time Frame: 0-6 weeks after the circumcision procedure
|
Includes intra-operative and post-operative complications such as bleeding, infection, and cosmetic problems
|
0-6 weeks after the circumcision procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uptake of NMC
Time Frame: Ongoing, over the course of the study (1.5 years)
|
Defined as % of parents of newborn boys approached during recruitment who consent to having their sons cirucumcised
|
Ongoing, over the course of the study (1.5 years)
|
|
Provider Preferences
Time Frame: Upon completion of training in NMC
|
Measure of provider preferences among 3 circumcision devices being compared
|
Upon completion of training in NMC
|
|
Parent Satisfaction
Time Frame: 6 weeks following the circumcision procedure
|
Score, between 0 and 100, of each parent's satisfaction with the outcome of the NMC procedure
|
6 weeks following the circumcision procedure
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Elizabeth M Stringer, MD, University of Alabama at Birmingham and Centre for Infectious Disease Research of Zambia
- Principal Investigator: Kasonde Bowa, MD, University Teaching Hospital, Lusaka, Zambia
- Principal Investigator: John Kachimba, MD, University Teaching Hospital, Lusaka, Zambia
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PS123541-06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Male Circumcision
-
Johns Hopkins Bloomberg School of Public HealthMRC/UVRI and LSHTM Uganda Research Unit; Rakai Health Sciences ProgramCompletedNeonatal Male Circumcision
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Medical University of South CarolinaCompleted
-
Simunye Primary Health CareCompleted
-
Kocatepe UniversityCompleted
-
FHI 360Weill Medical College of Cornell University; Bill and Melinda Gates Foundation and other collaboratorsCompletedMale CircumcisionKenya, Zambia
Clinical Trials on Neonatal male circumcision
-
Weill Medical College of Cornell UniversityEngenderHealthCompletedHIV Infections | HIV Prevention | Male CircumcisionKenya
-
French National Agency for Research on AIDS and...TerminatedHIV Infections | Herpes Genitalis | Venereal DiseasesSouth Africa
-
Wawer, Maria J., M.D.Johns Hopkins Bloomberg School of Public Health; MRC/UVRI and LSHTM Uganda... and other collaboratorsUnknownHIV Infections | Sexually Transmitted Diseases | Papillomavirus Infections | Gonorrhea | Chlamydia Infections | Syphilis | Genital Herpes | Bacterial VaginosisUganda
-
National Institute of Allergy and Infectious Diseases...Completed
-
EngenderHealthWeill Medical College of Cornell University; Kenya Ministry of Health; Kenya...CompletedHuman Immunodeficiency VirusKenya
-
National Institute of Allergy and Infectious Diseases...Fogarty International Center of the National Institute of HealthCompletedHIV Infections | Syphilis | Genital Diseases, Male | Herpesvirus 2, HumanUganda
-
University of WashingtonCenters for Disease Control and Prevention; University of Zimbabwe; Ministry... and other collaboratorsCompleted
-
National Center for AIDS/STD Control and Prevention...Sichuan Center for Disease Control and Prevention; Guizhou Center for Disease... and other collaboratorsUnknownHIV | Syphilis | Herpesvirus 2, HumanChina
-
FHI 360University of Illinois at Chicago; Bill and Melinda Gates Foundation; Nyanza... and other collaboratorsCompleted
-
University of Illinois at ChicagoNational Institute of Allergy and Infectious Diseases (NIAID); Atma Jaya Catholic...Completed